Literature DB >> 18563077

New dimensions of CIITA.

Walter Reith, Jeremy M Boss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18563077      PMCID： PMC2659346          DOI： 10.1038/ni0708-713

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  12 in total

1.  MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.

Authors:  Salomé LeibundGut-Landmann; Jean-Marc Waldburger; Caetano Reis e Sousa; Hans Acha-Orbea; Walter Reith
Journal:  Nat Immunol       Date:  2004-08-22       Impact factor: 25.606

2.  Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

Authors:  A Muhlethaler-Mottet; L A Otten; V Steimle; B Mach
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

3.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

Authors:  V Steimle; L A Otten; M Zufferey; B Mach
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

4.  Interferon-gamma-induced chromatin remodeling at the CIITA locus is BRG1 dependent.

Authors:  Samantha G Pattenden; Robert Klose; Elizabeth Karaskov; Rod Bremner
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

5.  The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.

Authors:  Rajini Mudhasani; Joseph D Fontes
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

6.  Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.

Authors:  Ann C Morris; Guy W Beresford; Myesha R Mooney; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 7.  Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes.

Authors:  Salomé LeibundGut-Landmann; Jean-Marc Waldburger; Michal Krawczyk; Luc A Otten; Tobias Suter; Adriano Fontana; Hans Acha-Orbea; Walter Reith
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

Review 8.  Spatial organization of gene expression: the active chromatin hub.

Authors:  Wouter de Laat; Frank Grosveld
Journal:  Chromosome Res       Date:  2003       Impact factor: 4.620

9.  The insulator factor CTCF controls MHC class II gene expression and is required for the formation of long-distance chromatin interactions.

Authors:  Parimal Majumder; Jorge A Gomez; Brian P Chadwick; Jeremy M Boss
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

10.  Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.

Authors:  J M Waldburger; T Suter; A Fontana; H Acha-Orbea; W Reith
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307
View more
  5 in total

1.  Kaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3.

Authors:  L M Butler; H C Jeffery; R L Wheat; H M Long; P C Rae; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 2.  Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.

Authors:  Clifford V Harding; W Henry Boom
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

3.  Class II, major histocompatibility complex, transactivator (CIITA) in channel catfish: identification and expression patterns responding to different pathogens.

Authors:  Yang Liu; Yanqing Meng; Qilong Wang; Zhenxia Sha
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

Review 4.  Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model.

Authors:  Anna E Kersh; Maiko Sasaki; Lee A Cooper; Haydn T Kissick; Brian P Pollack
Journal:  Front Pharmacol       Date:  2016-09-26       Impact factor: 5.810

5.  Fine mapping and functional studies of risk variants for type 1 diabetes at chromosome 16p13.13.

Authors:  M Joseph Tomlinson; Achilleas Pitsillides; Rebecca Pickin; Matthew Mika; Keith L Keene; Xuanlin Hou; Josyf Mychaleckyj; Wei-Min Chen; Patrick Concannon; Suna Onengut-Gumuscu
Journal:  Diabetes       Date:  2014-07-09       Impact factor: 9.461
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.